{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:09:43Z","timestamp":1783033783391,"version":"3.54.6"},"reference-count":172,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.tem.2020.04.007","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T19:15:51Z","timestamp":1591384551000},"page":"742-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Tibolone as Hormonal Therapy and Neuroprotective Agent"],"prefix":"10.1016","volume":"31","author":[{"given":"Juan Pablo","family":"Del R\u00edo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Hidalgo-Lanussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Miguel","family":"Garcia-Segura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6644-1971","authenticated-orcid":false,"given":"George E.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2020.04.007_bb0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1043-2760(02)00611-2","article-title":"Estrogens and neuroprotection","volume":"13","author":"Wise","year":"2002","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fpubh.2018.00141","article-title":"Steroid hormones and their action in women\u2019s brains: the importance of hormonal balance","volume":"6","author":"Del R\u00edo","year":"2018","journal-title":"Front. Public Health"},{"key":"10.1016\/j.tem.2020.04.007_bb0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of the North American Menopause Society","volume":"24","author":"Pinkerton","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrn3856","article-title":"The neuroprotective actions of oestradiol and oestrogen receptors","volume":"16","author":"Arevalo","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tem.2020.04.007_bb0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GME.0000000000000523","article-title":"Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy","volume":"23","author":"Pinkerton","year":"2016","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2016.05.013","article-title":"Hormone replacement therapy and the risk of endometrial cancer: a systematic review","volume":"91","author":"Sj\u00f6gren","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0040","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/annonc\/mdy212","article-title":"Different menopausal hormone regimens and risk of breast cancer","volume":"29","author":"Brusselaers","year":"2018","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tem.2020.04.007_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/09513590400030020","article-title":"The need for tissue selective menopausal agents","volume":"21","author":"Eden","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0050","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tem.2020.04.007_bb0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.maturitas.2004.02.012","article-title":"Tissue-selectivity: the mechanism of action of tibolone","volume":"48","author":"Kloosterboer","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0060","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/ijc.31267","article-title":"Tibolone and risk of gynecological hormone sensitive cancer","volume":"142","author":"L\u00f8kkegaard","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tem.2020.04.007_bb0065","doi-asserted-by":"crossref","first-page":"8630764","DOI":"10.1155\/2017\/8630764","article-title":"Effects of tibolone on the central nervous system: clinical and experimental approaches","volume":"2017","author":"Pinto-Almaz\u00e1n","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.tem.2020.04.007_bb0070","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1345\/aph.1D462","article-title":"Tibolone: a unique version of hormone replacement therapy","volume":"38","author":"Swegle","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.tem.2020.04.007_bb0075","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/j.1365-2826.2007.01611.x","article-title":"Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes","volume":"19","author":"Guzm\u00e1n","year":"2018","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jsbmb.2009.03.008","article-title":"Regulation of activities of steroid hormone receptors by tibolone and its primary metabolites","volume":"116","author":"Escande","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0085","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/jpet.105.091587","article-title":"Tibolone metabolism in human liver is catalyzed by 3\u03b1\/3\u03b2-hydroxysteroid dehydrogenase activities of the four isoforms of the aldo-keto reductase (AKR) 1C subfamily","volume":"316","author":"Steckelbroeck","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tem.2020.04.007_bb0090","doi-asserted-by":"crossref","first-page":"20162","DOI":"10.1074\/jbc.270.34.20162","article-title":"Substrate specificity, gene structure, and tissue-specific distribution of multiple human 3 alpha-hydroxysteroid dehydrogenases","volume":"270","author":"Khanna","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tem.2020.04.007_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2006.09.037","article-title":"Metabolism of exogenous sex steroids and effect on brain functions with a focus on tibolone","volume":"102","author":"Verheul","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0039-128X(02)00021-1","article-title":"Estrogenic effects of 7\u03b1-methyl-17\u03b1-ethynylestradiol: a newly discovered tibolone metabolite","volume":"67","author":"Bodine","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2020.04.007_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0378-5122(87)90038-7","article-title":"Clinical profile of Org OD 14","volume":"9","author":"Tax","year":"1987","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0110","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/13697137.2011.580639","article-title":"Historical milestones in the development of tibolone (Livial\u00ae)","volume":"14","author":"Kloosterboer","year":"2011","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","article-title":"Tibolone for postmenopausal women\u202f: systematic review of randomized trials","volume":"87","author":"Modelska","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1124\/dmd.106.014159","article-title":"Pharmacokinetic parameters of tibolone and metabolites in plasma, urine, feces, and bile from ovariectomized cynomolgus monkeys after a single dose or multiple doses of tibolone","volume":"35","author":"Verheul","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tem.2020.04.007_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4067\/S0716-97602005000200014","article-title":"In vivo and in vitro estrogenic and progestagenic actions of tibolone","volume":"38","author":"Sadarangani","year":"2005","journal-title":"Biol. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/cmt.4.1.28.41","article-title":"The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women","volume":"4","author":"Laan","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0135","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/09513590400021151","article-title":"Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels \u2013 an association with mammographic density","volume":"20","author":"Hofling","year":"2005","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0140","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0015-0282(00)01768-4","article-title":"Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy","volume":"75","author":"D\u00f6ren","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0145","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.maturitas.2005.02.011","article-title":"Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group","volume":"51","author":"Kenemans","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0150","first-page":"2","article-title":"Postmenopausal tibolone therapy: biologic principles and applied clinical practice","volume":"9","author":"Notelovitz","year":"2007","journal-title":"MedGenMed"},{"key":"10.1016\/j.tem.2020.04.007_bb0155","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/09513590.2010.488770","article-title":"Effects of menopause and tibolone on different cardiovascular biomarkers in healthy women","volume":"27","author":"Vassalle","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.steroids.2005.11.003","article-title":"Sulfation of tibolone metabolites by human postmenopausal liver and small intestinal sulfotransferases (SULTs)","volume":"71","author":"Wang","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2020.04.007_bb0165","first-page":"30","article-title":"The important roles of steroid sulfatase and sulfotransferases in gynecological diseases","volume":"7","author":"Ri\u017ener","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tem.2020.04.007_bb0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2009.02.017","article-title":"Transcriptional control of human steroid sulfatase","volume":"115","author":"Nardi","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0175","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/dmd.30.2.106","article-title":"The in vivo human metabolism of tibolone","volume":"30","author":"Vos","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tem.2020.04.007_bb0180","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jsbmb.2004.01.005","article-title":"Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases","volume":"88","author":"Falany","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0303-7207(01)00606-2","article-title":"Tibolone: a compound with tissue specific inhibitory effects on sulfatase","volume":"183","author":"Gooyer","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0190","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bone.2006.03.006","article-title":"Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone","volume":"39","author":"Maran","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.tem.2020.04.007_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CIA.S1043","article-title":"Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence","volume":"3","author":"Garefalakis","year":"2008","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.tem.2020.04.007_bb0200","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2012.11.001","article-title":"Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study","volume":"74","author":"Polisseni","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tem.2020.04.007_bb0210","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1471-0528.2007.01537.x","article-title":"Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability","volume":"114","author":"Hammar","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.tem.2020.04.007_bb0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.gme.0000247016.41007.c9","article-title":"Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study","volume":"13","author":"Swanson","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0220","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1210\/jcem.86.10.7937","article-title":"Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose-finding studies","volume":"86","author":"Gallagher","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0225","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2020.04.007_bb0230","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0235","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00198-007-0545-3","article-title":"Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women","volume":"19","author":"Delmas","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2020.04.007_bb0240","first-page":"645","article-title":"Official position of the Chilean Society of Climacteric on the management of climacteric women","volume":"138","author":"Bl\u00fcmel","year":"2010","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.tem.2020.04.007_bb0245","first-page":"1","article-title":"Spanish Menopause Society position statement: use of tibolone in postmenopausal women","volume":"20","author":"Mendoza","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0250","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/13697131003681458","article-title":"Updated clinical recommendations for the use of tibolone in Asian women","volume":"13","author":"Huang","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0255","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1471-0528.1999.tb08436.x","article-title":"Long term effects of tibolone on the genital tract in postmenopausal women","volume":"106","author":"Morris","year":"1999","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"10.1016\/j.tem.2020.04.007_bb0260","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5122(95)00930-J","article-title":"Changes in sex behaviour after menopause: effects of tibolone","volume":"22","author":"Palacios","year":"1995","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-5122(96)01069-9","article-title":"Effect on sexual life \u2013 a comparison between tibolone and a continuous estradiol-norethisterone acetate regimen","volume":"26","author":"Nathorst-B\u00f6\u00f6s","year":"1997","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13697130903009195","article-title":"Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women","volume":"13","author":"Ziaei","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0275","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s13224-012-0297-7","article-title":"A comparative study of CEE, tibolone, and DHEA as hormone replacement therapy for surgical menopause","volume":"63","author":"Gupta","year":"2013","journal-title":"J. Obstet. Gynaecol. India"},{"key":"10.1016\/j.tem.2020.04.007_bb0280","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/GME.0000000000001230","article-title":"Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women","volume":"25","author":"Huang","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0285","first-page":"13","article-title":"Effects of tibolone on endogenous nitric oxide (nitrite\/nitrate levels) in postmenopausal women","volume":"47","author":"Akg\u00fcl","year":"2002","journal-title":"Int. J. Fertil. Womens Med."},{"key":"10.1016\/j.tem.2020.04.007_bb0290","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0015-0282(02)03295-8","article-title":"Effects of tibolone on plasma levels of nitric oxide in postmenopausal women","volume":"78","author":"Cicinelli","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0295","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/HYPERTENSIONAHA.107.105742","article-title":"Menopause and hypertension: an age-old debate","volume":"51","author":"Coylewright","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tem.2020.04.007_bb0300","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.fertnstert.2018.07.1152","article-title":"Cardiovascular health and ovarian aging","volume":"110","author":"Quinn","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0305","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/ijcp.12903","article-title":"Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options","volume":"70","author":"Anagnostis","year":"2016","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.tem.2020.04.007_bb0310","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2010.10.076","article-title":"A \u201cwindow of opportunity:\u201d the reduction of coronary heart disease and total mortality with menopausal therapies is age and time dependent","volume":"1379","author":"Hodis","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0315","doi-asserted-by":"crossref","first-page":"H1765","DOI":"10.1152\/ajpheart.00041.2018","article-title":"A heartfelt message, estrogen replacement therapy: use it or lose it","volume":"315","author":"Speth","year":"2018","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0320","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.maturitas.2017.02.009","article-title":"The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: a systematic review and meta-analysis","volume":"99","author":"Anagnostis","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0325","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/eurheartj\/ehi724","article-title":"Does tibolone exacerbate atherosclerosis?","volume":"27","author":"Clarkson","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.tem.2020.04.007_bb0330","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/01.ATV.18.12.1844","article-title":"Tibolone prevents atherosclerotic lesion formation in cholesterol-fed, ovariectomized rabbits","volume":"18","author":"Zandberg","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0335","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mob.2001.111098","article-title":"Hemodynamic response to tibolone in reproductive and nonreproductive tissues in the sheep","volume":"184","author":"Zoma","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tem.2020.04.007_bb0340","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/gerona\/gls210","article-title":"Beneficial effects of tibolone on blood pressure and liver redox status in ovariectomized rats with renovascular hypertension","volume":"68","author":"Gilglioni","year":"2013","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0345","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/09513599909167556","article-title":"Decrease of serum endothelin levels with postmenopausal hormone replacement therapy or tibolone","volume":"13","author":"Haenggi","year":"1999","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0350","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1210\/jc.2003-032189","article-title":"Tibolone activates nitric oxide synthesis in human endothelial cells","volume":"89","author":"Simoncini","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0355","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2007.04.011","article-title":"In vitro effects of tibolone and its metabolites on human vascular coronary cells","volume":"58","author":"Seeger","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0360","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1933719106298684","article-title":"Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogesterone acetate","volume":"14","author":"Verheul","year":"2007","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0365","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1124\/dmd.106.014118","article-title":"Selective tissue distribution of tibolone metabolites in mature ovariectomized female cynomolgus monkeys after multiple doses of tibolone","volume":"35","author":"Verheul","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tem.2020.04.007_bb0370","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974\u20132000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0375","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0378-5122(84)90046-X","article-title":"Org OD 14: long-term effects on serum lipoproteins","volume":"6","author":"Farish","year":"1984","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0380","first-page":"451","article-title":"A double-blind cross-over study on the effects of ORG OD14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women","volume":"102","author":"Crona","year":"1983","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.tem.2020.04.007_bb0385","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.maturitas.2004.02.011","article-title":"Multisystem evaluations of the long-term effects of tibolone on postmenopausal monkeys","volume":"48","author":"Clarkson","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0390","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal hormone therapy and long-term all-cause and cause-specific mortality","volume":"318","author":"Manson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2020.04.007_bb0395","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2020.04.007_bb0400","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2020.04.007_bb0405","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1055\/s-0037-1614156","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy: results of the randomized, double-blind, placebo-controlled Estrogen in Venous Thromboembolism Trial (EVTET)","volume":"84","author":"H\u00f8ibraaten","year":"2000","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.tem.2020.04.007_bb0410","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0378-5122(02)00202-5","article-title":"Haemostatic risk factors in healthy postmenopausal women taking hormone replacement therapy","volume":"43","author":"Norris","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2006.10.013","article-title":"Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis","volume":"120","author":"Eilertsen","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0420","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1161\/01.ATV.0000091502.96745.95","article-title":"Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study","volume":"23","author":"Koh","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0425","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1527-3466.2007.00007.x","article-title":"Cardiovascular effects of tibolone: a selective tissue estrogenic activity regulator","volume":"25","author":"Campisi","year":"2007","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.tem.2020.04.007_bb0430","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.phrs.2017.07.024","article-title":"Effects of tibolone on fibrinogen and antithrombin III: a systematic review and meta-analysis of controlled trials","volume":"124","author":"Bala","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0435","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9378(03)00950-5","article-title":"Sex hormone-binding globulin \u2013 a surrogate marker for the prothrombotic effects of combined oral contraceptives","volume":"190","author":"Van Rooijen","year":"2004","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tem.2020.04.007_bb0440","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MBC.0000000000000784","article-title":"Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment","volume":"30","author":"Eilertsen","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.tem.2020.04.007_bb0445","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2020.04.007_bb0450","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2020.04.007_bb0455","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13697130500247669","article-title":"The Million Women Study \u2013 is it believable?","volume":"8","author":"Farmer","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0460","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1258\/136218006777525730","article-title":"Tibolone is not used as a first-line therapy: implications for the Million Women Study analysis","volume":"12","author":"Seeley","year":"2006","journal-title":"J. Br. Menopause Soc."},{"key":"10.1016\/j.tem.2020.04.007_bb0465","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.gyobfe.2006.01.027","article-title":"Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France","volume":"34","author":"Jamin","year":"2006","journal-title":"Gynecol. Obstet. Fertil."},{"key":"10.1016\/j.tem.2020.04.007_bb0470","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0015-0282(02)03203-X","article-title":"In vitro studies of tibolone in breast cells","volume":"78","author":"Gompel","year":"2002","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0475","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1590\/SO100-720320150005333","article-title":"Efeitos da tibolona sobre o par\u00eanquima mam\u00e1rio: estudo experimental","volume":"37","author":"Marques","year":"2015","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"10.1016\/j.tem.2020.04.007_bb0480","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1158\/1078-0432.CCR-06-2700","article-title":"Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients: results from STEM trial","volume":"13","author":"Kubista","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0485","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.maturitas.2004.06.022","article-title":"Tissue-selective effects of tibolone on the breast","volume":"49","author":"Kloosterboer","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0490","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-016-0750-0","article-title":"Mammographic density and breast cancer risk: a mediation analysis","volume":"18","author":"Rice","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0495","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr3097","article-title":"Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy","volume":"14","author":"Bundred","year":"2012","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0500","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/1055-9965.EPI-16-0240","article-title":"Postmenopausal hormone therapy and breast cancer prognostic characteristics: a linkage between nationwide registries","volume":"25","author":"Roman","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.tem.2020.04.007_bb0505","author":"NICE"},{"key":"10.1016\/j.tem.2020.04.007_bb0510","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jc.2006-2207","article-title":"Endometrial effects of tibolone","volume":"92","author":"Archer","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0515","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.maturitas.2007.07.005","article-title":"Effects of tibolone and raloxifene on health-related quality of life and sexual function","volume":"58","author":"Nijland","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0520","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1471-0528.2002.01338.x","article-title":"Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women","volume":"109","author":"Huber","year":"2002","journal-title":"BJOG"},{"key":"10.1016\/j.tem.2020.04.007_bb0525","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/cmt.4.3.203.208","article-title":"Effects of tibolone on the endometrium","volume":"4","author":"V\u00f6lker","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.tem.2020.04.007_bb0530","first-page":"963","article-title":"Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas","volume":"10","author":"Sherman","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.tem.2020.04.007_bb0535","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.tem.2020.04.007_bb0540","first-page":"1075","article-title":"Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition","volume":"22","author":"Tsilidis","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.tem.2020.04.007_bb0545","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2017.07.012","article-title":"Menopausal hormone therapy and cancer risk: an overestimated risk?","volume":"84","author":"Simin","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tem.2020.04.007_bb0550","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s13318-017-0458-2","article-title":"Effects of human sulfotransferase 2A1 genetic polymorphisms 3 on the sulfation of tibolone","volume":"43","author":"Miller","year":"2018","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tem.2020.04.007_bb0555","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0361-9230(98)00172-5","article-title":"Localisation of dehydroepiandrosterone sulphotransferase in adult rat brain","volume":"48","author":"Aldred","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.tem.2020.04.007_bb0560","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1177\/002215540305101209","article-title":"Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study","volume":"51","author":"Liyou","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tem.2020.04.007_bb0565","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3389\/fpsyg.2019.01319","article-title":"Estradiol fluctuation, sensitivity to stress, and depressive symptoms in the menopause transition: a pilot study","volume":"10","author":"Gordon","year":"2019","journal-title":"Front. Psychol."},{"key":"10.1016\/j.tem.2020.04.007_bb0570","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1258\/mi.2008.008019","article-title":"Depression during menopausal transition: a review of treatment strategies and pathophysiological correlates","volume":"14","author":"Frey","year":"2008","journal-title":"Menopause Int."},{"key":"10.1016\/j.tem.2020.04.007_bb0575","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamapsychiatry.2017.3998","article-title":"Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition: a randomized clinical trial","volume":"75","author":"Gordon","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.tem.2020.04.007_bb0580","first-page":"81","article-title":"Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women","volume":"6","author":"Kicovic","year":"1982","journal-title":"Reproduccion"},{"key":"10.1016\/j.tem.2020.04.007_bb0585","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-5122(88)90095-3","article-title":"Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo","volume":"9","author":"Crona","year":"1988","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0590","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/154099903321154121","article-title":"Failure of tibolone to potentiate the pharmacological effect of fluoxetine in postmenopausal major depression","volume":"12","author":"Berlanga","year":"2003","journal-title":"J. Women's Health (Larchmt)"},{"key":"10.1016\/j.tem.2020.04.007_bb0595","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jad.2018.04.103","article-title":"Tibolone improves depression in women through the menopause transition: a double-blind randomised controlled trial of adjunctive tibolone","volume":"236","author":"Kulkarni","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.tem.2020.04.007_bb0600","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.gme.0000191372.79052.d3","article-title":"Effect of tibolone administration on central and peripheral levels of allopregnanolone and\u202fbeta-endorphin in female rats","volume":"13","author":"Genazzani","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.tem.2020.04.007_bb0605","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000293687","article-title":"Steroid replacement treatment increases beta-endorphin and beta-lipotropin plasma levels in postmenopausal women","volume":"26","author":"Genazzani","year":"1988","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.tem.2020.04.007_bb0610","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-5122(00)00147-X","article-title":"The effect of tibolone versus continuous combined norethisterone acetate and oestradiol on memory, libido and mood of postmenopausal women: a pilot study","volume":"36","author":"Albertazzi","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2020.04.007_bb0615","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11920-018-0972-1","article-title":"Estrogens, aging, and working memory","volume":"20","author":"Hampson","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.tem.2020.04.007_bb0620","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00004714-200202000-00010","article-title":"Cognitive effects of 10 years of hormone-replacement therapy with tibolone","volume":"22","author":"Fluck","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.tem.2020.04.007_bb0625","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/bs.vh.2016.08.004","article-title":"Estrogen receptors modulation of anxiety-like behavior","volume":"103","author":"Borrow","year":"2017","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.tem.2020.04.007_bb0630","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/nedt.2006.2.3.299","article-title":"Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women","volume":"2","author":"Genazzani","year":"2006","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.tem.2020.04.007_bb0635","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","article-title":"The role of allopregnanolone in depression and anxiety","volume":"113","author":"Sch\u00fcle","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0640","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.psyneuen.2006.05.004","article-title":"Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women","volume":"31","author":"Grigorova","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.tem.2020.04.007_bb0645","first-page":"702","article-title":"\u201cAdd-back\u201d estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri","volume":"82","author":"Davis","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2020.04.007_bb0650","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.fertnstert.2007.05.061","article-title":"Tibolone reverses the cognitive effects caused by leuprolide acetate administration, improving mood and quality of life in patients with symptomatic uterine leiomyomas","volume":"90","author":"Palomba","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.tem.2020.04.007_bb0655","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1080\/14656566.2019.1645122","article-title":"Pharmacotherapeutic approaches to treating depression during the perimenopause","volume":"20","author":"Garay","year":"2019","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.tem.2020.04.007_bb0660","first-page":"86","article-title":"Anti-tumor-promoting activity of tibolone and its metabolites","volume":"58","author":"Colombo","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.tem.2020.04.007_bb0665","doi-asserted-by":"crossref","first-page":"H1501","DOI":"10.1152\/ajpheart.00227.2004","article-title":"Neuroprotection by a selective estrogen receptor \u03b2 agonist in a mouse model of global ischemia","volume":"287","author":"Carswell","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0670","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.0703783104","article-title":"Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)\u03b1 and ER\u03b2 ligand treatment","volume":"104","author":"Tiwari-Woodruff","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tem.2020.04.007_bb0675","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2014.10.002","article-title":"Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway","volume":"145","author":"Ishihara","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.tem.2020.04.007_bb0680","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fnagi.2014.00132","article-title":"Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury","volume":"6","author":"Barreto","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tem.2020.04.007_bb0685","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0306-4522(02)00239-7","article-title":"Effects of long-term hormone replacement and of tibolone on choline acetyltransferase and acetylcholinesterase activities in the brains of ovariectomized, cynomolgus monkeys","volume":"113","author":"Gibbs","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.tem.2020.04.007_bb0690","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s11064-014-1385-0","article-title":"Tibolone prevents oxidation and ameliorates cholinergic deficit induced by ozone exposure in the male rat hippocampus","volume":"39","author":"Farf\u00e1n-Garc\u00eda","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0695","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.yhbeh.2011.10.005","article-title":"Chronic administration of tibolone modulates anxiety-like behavior and enhances cognitive performance in ovariectomized rats","volume":"61","author":"Espinosa-Raya","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.tem.2020.04.007_bb0700","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0006-8993(00)02713-X","article-title":"Gender differences and the effects of synthetic exogenous and non-synthetic estrogens in focal cerebral ischemia","volume":"878","author":"Vergouwen","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0705","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nrl.2014.03.002","article-title":"Effect of tibolone on dendritic spine density in the rat hippocampus","volume":"30","author":"Beltr\u00e1n-Campos","year":"2014","journal-title":"Neurologia"},{"key":"10.1016\/j.tem.2020.04.007_bb0710","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cobeha.2018.03.011","article-title":"Estradiol and hippocampal memory in female and male rodents","volume":"23","author":"Frick","year":"2018","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0715","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1007\/s12035-018-1008-x","article-title":"The synthetic steroid tibolone decreases reactive gliosis and neuronal death in the cerebral cortex of female mice after a stab wound injury","volume":"55","author":"Crespo-Castrillo","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0720","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/bph.13125","article-title":"The contribution of astrocytes and microglia to traumatic brain injury","volume":"173","author":"Karve","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tem.2020.04.007_bb0725","article-title":"Lipotoxicity, neuroinflammation, glial cells and estrogenic compounds","volume":"32","author":"Hidalgo-Lanussa","year":"2019","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0730","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pneurobio.2016.06.002","article-title":"Regulation of astroglia by gonadal steroid hormones under physiological and pathological conditions","volume":"144","author":"Acaz-Fonseca","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0735","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.mce.2014.01.009","article-title":"Role of astrocytes in the neuroprotective actions of 17\u03b2-estradiol and selective estrogen receptor modulators","volume":"389","author":"Acaz-Fonseca","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0740","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2016.05.024","article-title":"Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression","volume":"433","author":"Avila-Rodriguez","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0745","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/glia.440080408","article-title":"Differential activation of microglia and astrocytes in aniso- and isomorphic gliotic tissue","volume":"8","author":"Fernaud-Espinosa","year":"1993","journal-title":"Glia"},{"key":"10.1016\/j.tem.2020.04.007_bb0750","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1742-2094-6-30","article-title":"Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling","volume":"6","author":"Gatson","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tem.2020.04.007_bb0755","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/glia.20644","article-title":"Steroid hormone receptor expression and function in microglia","volume":"56","author":"Sierra","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.tem.2020.04.007_bb0760","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.steroids.2017.12.010","article-title":"Sex-related differences in oxidative stress and neurodegeneration","volume":"133","author":"Tenkorang","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.tem.2020.04.007_bb0765","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/10641963.2016.1226894","article-title":"Impact of high fat\/high salt diet on myocardial oxidative stress","volume":"39","author":"Mayyas","year":"2017","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.tem.2020.04.007_bb0770","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/bs.pmbts.2016.12.016","article-title":"Metabolic syndrome and the cellular phase of Alzheimer\u2019s disease","volume":"146","author":"Pugazhenthi","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0775","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbi.2014.04.001","article-title":"Obesity and neuroinflammation: a pathway to cognitive impairment","volume":"42","author":"Miller","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tem.2020.04.007_bb0780","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/a-0659-9928","article-title":"Acute administration of tibolone prevents oxidative stress in ovariectomized rats fed high-fat-and-fructose diet","volume":"127","author":"Ang\u00e9lica","year":"2019","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.tem.2020.04.007_bb0785","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/09513590.2014.943727","article-title":"Antioxidant effect of the active metabolites of tibolone","volume":"31","author":"Stark","year":"2015","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0790","doi-asserted-by":"crossref","first-page":"441","DOI":"10.33588\/rn.5810.2013357","article-title":"Neuroprotective effects of tibolone against oxidative stress induced by ozone exposure","volume":"58","author":"Pinto-Almaz\u00e1n","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.tem.2020.04.007_bb0795","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1152\/physrev.00004.2002","article-title":"Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior","volume":"82","author":"Mattson","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2020.04.007_bb0800","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1007\/s12035-017-0777-y","article-title":"Tibolone reduces oxidative damage and inflammation in microglia stimulated with palmitic acid through mechanisms involving estrogen receptor beta","volume":"55","author":"Hidalgo-Lanussa","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0805","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s12035-018-1212-8","article-title":"Neuroglobin expression in the brain: a story of tissue homeostasis preservation","volume":"56","author":"Van Acker","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tem.2020.04.007_bb0810","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fneur.2016.00146","article-title":"Protection by neuroglobin expression in brain pathologies","volume":"7","author":"Baez","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tem.2020.04.007_bb0815","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/ijms17111817","article-title":"Neuroglobin, a factor playing for nerve cell survival","volume":"17","author":"Guidolin","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0820","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jne.12007","article-title":"17\u03b2-Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor \u03b2-mediated neuroglobin up-regulation","volume":"25","author":"De Marinis","year":"2013","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.tem.2020.04.007_bb0825","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/iub.426","article-title":"Neuroglobin, estrogens, and neuroprotection","volume":"63","author":"De Marinis","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.tem.2020.04.007_bb0830","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4103\/1673-5374.228726","article-title":"Effect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of tau in the hippocampus of rats exposed to ozone","volume":"13","author":"Pinto-Almaz\u00e1n","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0835","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4103\/1673-5374.205098","article-title":"Tibolone modulates neuronal plasticity through regulating tau, GSK3\u03b2\/Akt\/PI3K pathway and CDK5 p35\/p25 complexes in the hippocampus of aged male mice","volume":"12","author":"Neri-G\u00f3mez","year":"2017","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.tem.2020.04.007_bb0840","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00498254.2010.535923","article-title":"Mechanisms of gender-specific regulation of mouse sulfotransferases (Sults)","volume":"41","author":"Alnouti","year":"2011","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tem.2020.04.007_bb0845","article-title":"The role of sex and sex hormones in neurodegenerative diseases","volume":"41","author":"Vegeto","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.tem.2020.04.007_bb0850","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tem.2020.04.007_bb0855","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017017156","article-title":"Neurosteroids and ischemic stroke: progesterone a promising agent in reducing the brain injury in ischemic stroke","volume":"36","author":"Andrabi","year":"2017","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"10.1016\/j.tem.2020.04.007_bb0860","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamapsychiatry.2019.1842","article-title":"Effect of adjunctive estradiol on schizophrenia among women of childbearing age","volume":"76","author":"Weiser","year":"2019","journal-title":"JAMA Psychiatry"}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276020300989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276020300989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:40:29Z","timestamp":1760906429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276020300989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":172,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1043276020300989"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2020.04.007","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tibolone as Hormonal Therapy and Neuroprotective Agent","name":"articletitle","label":"Article Title"},{"value":"Trends in Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tem.2020.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}